Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.

Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, Topol EJ.

Am J Cardiol. 2005 May 15;95(10):1218-22.

PMID:
15877994
2.
3.
4.
6.

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators..

Ann Intern Med. 2009 Mar 17;150(6):379-86.

PMID:
19293071
7.

[Aspirin dosage for prevention of cerebral infarct: arguments for low dosage].

Hennerici MG, Meairs S.

Nervenarzt. 1995 Dec;66(12):890-4; discussion 885. Review. German.

PMID:
8584072
8.

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

Warkentin AE, Donadini MP, Spencer FA, Lim W, Crowther M.

J Thromb Haemost. 2012 Apr;10(4):512-20. doi: 10.1111/j.1538-7836.2012.04635.x. Review.

9.

[Bleeding complications after treatment with clopidogrel and acetylsalicylic acid after acute coronary syndrome].

Kjaer J, Larsen CH, Poulsen TS, Møller JE, Mickley H.

Ugeskr Laeger. 2006 Sep 18;168(38):3209-14. Danish.

PMID:
17026894
10.

[Prevention of gastroduodenal complications in patients taking low-dose aspirin].

Chryssostalis A, Marck G, Sibilia J, Chaussade S.

Gastroenterol Clin Biol. 2004 Apr;28 Spec No 3:C84-9. Review. French.

PMID:
15366679
11.

Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.

[No authors listed]

Cardiovasc J Afr. 2009 May-Jun;20(3):205. No abstract available.

12.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators..

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
13.

Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis.

Lanas A, Wu P, Medin J, Mills EJ.

Clin Gastroenterol Hepatol. 2011 Sep;9(9):762-768.e6. doi: 10.1016/j.cgh.2011.05.020. Epub 2011 Jun 6.

PMID:
21699808
14.

[Aspirin in patients undergoing percutaneous coronary intervention].

Güleç S.

Anadolu Kardiyol Derg. 2007 Dec;7 Suppl 2:9-13. Review. Turkish.

15.

Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?

Laine L.

Aliment Pharmacol Ther. 2006 Sep 15;24(6):897-908. Review.

16.

Aspirin: benefit and risk in thromboprophylaxis.

Dickinson JP, Prentice CR.

QJM. 1998 Aug;91(8):523-38. Review.

PMID:
9893756
17.

Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.

Mardikar H, Deo D, Deshpande N, Mardikar M, Ghosh A, Munot K, Steinhubl S, Mukherjee D.

J Assoc Physicians India. 2008 May;56:321-4.

PMID:
18700638
18.

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.

Jolly SS, Pogue J, Haladyn K, Peters RJ, Fox KA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR.

Eur Heart J. 2009 Apr;30(8):900-7. doi: 10.1093/eurheartj/ehn417. Epub 2008 Sep 26.

PMID:
18819961

Supplemental Content

Support Center